Table 1. The inhibition of HLC-080 and Sorafenib on the proliferation of various cancer cells.

Cell lines	Organs	IC50 (µM)
		HLC-080	Sorafenib
U251	Brain	20.81±3.51	33.24±5.23
SH-SY5Y	Brain	45.36±5.24	32.70±5.81
MGC803	Stomach	15.68±3.95	20.83±4.18
BGC823	Stomach	26.94±4.75	37.26±5.41
Ketr3	Kidney	7.96±2.07	16.01±4.18
HT-29	Colon	1.83±0.35	9.37±1.18
HCT-8	Colon	5.53±1.29	18.27±3.52
HCT-116	Colon	5.66±0.96	12.93±2.89
HepG2	Liver	4.10±1.29	17.03±3.42
SMMC-7721	Liver	7.48±1.88	16.40±3.63
Bel7402	Liver	15.73±3.61	12.59±3.49
A549	Lung	27.64±4.77	29.60±4.61
A2780	Ovary	14.12±3.21	22.04±3.63
HELF	Normal lung	23.77±2.11	25.53±2.51